Cybersecurity remains a timely topic, it is a topic on which this Committee has an important role.

I just wanted to get back to HealthCare.gov, and my understanding is that companies are not actually perched on the HealthCare.gov but they are receiving--they are being given data from there.

I don't want in any way my statements or questions to suggest that everything is wonderful with HealthCare.gov or especially the D.C. website, which was completely atrocious once again for the second year in a row.

I was lead Democratic co-sponsor of the Small Airplane Revitalization Act.

It is important that we move this forward as quickly as possible.

With S&T's reauthorization, the committee has an opportunity to help launch a 21st Century research and development (R&D) organization that will serve as a model for Federal R&D.

I think it is important that we continue to work together on that, to do that.

I look forward to hearing what S&T is doing to improve these relationships and how they define their role within each phase of the technology development process.

I look forward to working with you and, hopefully, providing you with some of the tools you need to improve the R&D efforts at DHS.

I look forward to hearing from you, Dr. Brothers, on the changes you will be putting in place to ensure DHS R&D investments are well-managed.

I am disappointed that the success of the S&T Directorate continues to be limited by a lack of effective strategy and a lack of coordination resulting in some costly and, likely, preventable failures.